
### [NCIT:C8318](http://purl.obolibrary.org/obo/NCIT_C8318)
**Label:** Stage I Lymphoma

**Subclasses:** [NCIT:C8839](http://purl.obolibrary.org/obo/NCIT_C8839) (Stage I Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C8517](http://purl.obolibrary.org/obo/NCIT_C8517) (Stage I Hodgkin Lymphoma), [NCIT:C8859](http://purl.obolibrary.org/obo/NCIT_C8859) (Stage I Follicular Lymphoma), [NCIT:C8834](http://purl.obolibrary.org/obo/NCIT_C8834) (Stage I Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8659](http://purl.obolibrary.org/obo/NCIT_C8659) (Stage I Anaplastic Large Cell Lymphoma), [NCIT:C8854](http://purl.obolibrary.org/obo/NCIT_C8854) (Stage I Diffuse Large B-Cell Lymphoma), [NCIT:C8876](http://purl.obolibrary.org/obo/NCIT_C8876) (Stage I Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8653](http://purl.obolibrary.org/obo/NCIT_C8653) (Stage I Lymphoplasmacytic Lymphoma), [NCIT:C8672](http://purl.obolibrary.org/obo/NCIT_C8672) (Stage I Angioimmunoblastic T-cell Lymphoma), [NCIT:C94791](http://purl.obolibrary.org/obo/NCIT_C94791) (Stage I Childhood Non-Hodgkin Lymphoma), [NCIT:C8056](http://purl.obolibrary.org/obo/NCIT_C8056) (Stage I Childhood Hodgkin Lymphoma), [NCIT:C8078](http://purl.obolibrary.org/obo/NCIT_C8078) (Stage I Adult Immunoblastic Lymphoma), [NCIT:C8079](http://purl.obolibrary.org/obo/NCIT_C8079) (Stage I Adult Lymphoblastic Lymphoma), [NCIT:C8871](http://purl.obolibrary.org/obo/NCIT_C8871) (Stage I B Lymphoblastic Lymphoma), [NCIT:C5085](http://purl.obolibrary.org/obo/NCIT_C5085) (Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5064](http://purl.obolibrary.org/obo/NCIT_C5064) (Stage I Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8670](http://purl.obolibrary.org/obo/NCIT_C8670) (Stage I Nasal Type NK/T-Cell Lymphoma), [NCIT:C9032](http://purl.obolibrary.org/obo/NCIT_C9032) (Stage I Adult Hodgkin Lymphoma), [NCIT:C9252](http://purl.obolibrary.org/obo/NCIT_C9252) (Stage I Aggressive Adult Non-Hodgkin Lymphoma), [NCIT:C68678](http://purl.obolibrary.org/obo/NCIT_C68678) (Stage I Marginal Zone Lymphoma), [NCIT:C8080](http://purl.obolibrary.org/obo/NCIT_C8080) (Stage I Adult Burkitt Lymphoma), [NCIT:C8848](http://purl.obolibrary.org/obo/NCIT_C8848) (Stage I Burkitt Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5634](http://purl.obolibrary.org/obo/NCIT_C5634) (Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma), [NCIT:C8665](http://purl.obolibrary.org/obo/NCIT_C8665) (Stage I T-Cell Non-Hodgkin Lymphoma), [NCIT:C27308](http://purl.obolibrary.org/obo/NCIT_C27308) (Stage I B-Cell Non-Hodgkin Lymphoma), [NCIT:C8864](http://purl.obolibrary.org/obo/NCIT_C8864) (Stage I Nodal Marginal Zone Lymphoma), [NCIT:C8102](http://purl.obolibrary.org/obo/NCIT_C8102) (Stage I Adult Non-Hodgkin Lymphoma), [NCIT:C8520](http://purl.obolibrary.org/obo/NCIT_C8520) (Stage I Non-Hodgkin Lymphoma), [NCIT:C8465](http://purl.obolibrary.org/obo/NCIT_C8465) (Stage I Mantle Cell Lymphoma), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C8464](http://purl.obolibrary.org/obo/NCIT_C8464) (Stage I Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C9056](http://purl.obolibrary.org/obo/NCIT_C9056) (Stage I Childhood Lymphoblastic Lymphoma), [NCIT:C8682](http://purl.obolibrary.org/obo/NCIT_C8682) (Stage I Enteropathy-Associated T-Cell Lymphoma), [NCIT:C9185](http://purl.obolibrary.org/obo/NCIT_C9185) (Stage I Childhood Burkitt Lymphoma), [NCIT:C8690](http://purl.obolibrary.org/obo/NCIT_C8690) (Stage I Mature T- and NK-Cell Lymphoma), [NCIT:C8072](http://purl.obolibrary.org/obo/NCIT_C8072) (Stage I Grade 2 Follicular Lymphoma), [NCIT:C8073](http://purl.obolibrary.org/obo/NCIT_C8073) (Stage I Grade 3 Follicular Lymphoma), [NCIT:C8070](http://purl.obolibrary.org/obo/NCIT_C8070) (Stage I Small Lymphocytic Lymphoma), [NCIT:C8071](http://purl.obolibrary.org/obo/NCIT_C8071) (Stage I Grade 1 Follicular Lymphoma), [NCIT:C88150](http://purl.obolibrary.org/obo/NCIT_C88150) (Stage I Mycosis Fungoides and Sezary Syndrome), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27966](http://purl.obolibrary.org/obo/NCIT_C27966) (Stage I) 55.00%
- Thing 52.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39833](http://purl.obolibrary.org/obo/NCIT_C39833) (Schistosoma Hematobium-Related Bladder Verrucous Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 40.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 40.36%


